Analysts have clear opinions on INOV.
There are 2 analysts on the Wall offering 12 month price targets for Inovalon in the last 3 months. The average price target is $16.50 with a high forecast of $21.00 and a low forecast of $12.00. The average price target represents a -17.40% decrease from the last price of $19.98.
Inovalon Holdings, Inc. (INOV) is followed by 2 analysts on the street.
Sean Wieland from Piper Sandler rates it a Sell with a target of $12.00.
Similarly, 3 months ago Stephanie Davis of Citigroup Initiated a Buy with a target of $21.00.
The consensus on the street is Hold.
What does Inovalon Holdings, Inc.(INOV) do ?
Inovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded on September 11, 2014 and is headquartered in Bowie, MD.
Inovalon Holdings, Inc. (INOV) Insider Trades
Multiple company employees have indulged in significant insider trading. Inovalon Holdings, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):
CEO, COB, 10%, Dunleavy Keith R : P – Purchase(+$1,836,955) of INOV in the trading session of 2019-05-10.
COO Capitel Jason : P – Purchase(+$221,100) of INOV in the trading session of 2018-11-13.
Dir Roberts Lee D : P – Purchase(+$105,400) of Inovalon Holdings, Inc. in the trading session of 2018-06-08.
Looking for stocks just like INOV?
Based on Wall Street analyst research, several stocks are similar to INOV
– EVH [Info can be found here: https://www.nasdaq.com/market-activity/stocks/EVH ]
– NVTA [Info can be found here: https://www.nasdaq.com/market-activity/stocks/NVTA ]
– SYNH [Info can be found here: https://www.nasdaq.com/market-activity/stocks/SYNH ]